Literature DB >> 17487865

Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy.

Masayuki Nakamori1, Takashi Kimura, Harutoshi Fujimura, Masanori P Takahashi, Saburo Sakoda.   

Abstract

Myotonic dystrophy type1 (DM1) is a multisystemic disorder caused by a CTG repeat expansion in the DMPK gene. Aberrant mRNA splicing of several genes has been reported to contribute to some of the symptoms, including myotonia and insulin resistance, but the cause of muscle wasting is unknown. Dystrophin is a cytoskeletal protein that is required for structural stability and signaling at the sarcolemma and has several spliced isoforms. We investigated the alternative splicing of dystrophin in skeletal and cardiac muscle of DM1 patients by using reverse transcriptase-polymerase chain reaction and found that dystrophin isoforms lacking exon 71 or 78, which is suggested to encode an important region for protein binding and hydrophobicity, were significantly increased. We suggest that the aberrantly spliced dystrophin is responsible for the muscle wasting in DM1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487865     DOI: 10.1002/mus.20809

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

1.  Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.

Authors:  Linda L Bachinski; Keith A Baggerly; Valerie L Neubauer; Tamara J Nixon; Olayinka Raheem; Mario Sirito; Anna K Unruh; Jiexin Zhang; Lalitha Nagarajan; Lubov T Timchenko; Guillaume Bassez; Bruno Eymard; Josep Gamez; Tetsuo Ashizawa; Jerry R Mendell; Bjarne Udd; Ralf Krahe
Journal:  Neuromuscul Disord       Date:  2013-11-15       Impact factor: 4.296

2.  Aberrant Myokine Signaling in Congenital Myotonic Dystrophy.

Authors:  Masayuki Nakamori; Kohei Hamanaka; James D Thomas; Eric T Wang; Yukiko K Hayashi; Masanori P Takahashi; Maurice S Swanson; Ichizo Nishino; Hideki Mochizuki
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

3.  CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.

Authors:  Amanda J Ward; Mendell Rimer; James M Killian; James J Dowling; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2010-07-05       Impact factor: 6.150

4.  Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2.

Authors:  A Vihola; M Sirito; L L Bachinski; O Raheem; M Screen; T Suominen; R Krahe; B Udd
Journal:  Neuropathol Appl Neurobiol       Date:  2013-06       Impact factor: 8.090

5.  Cell type-specific abnormalities of central nervous system in myotonic dystrophy type 1.

Authors:  Masayuki Nakamori; Hiroshi Shimizu; Kotaro Ogawa; Yuhei Hasuike; Takashi Nakajima; Hidetoshi Sakurai; Toshiyuki Araki; Yukinori Okada; Akiyoshi Kakita; Hideki Mochizuki
Journal:  Brain Commun       Date:  2022-06-10

6.  Splicing biomarkers of disease severity in myotonic dystrophy.

Authors:  Masayuki Nakamori; Krzysztof Sobczak; Araya Puwanant; Steve Welle; Katy Eichinger; Shree Pandya; Jeannne Dekdebrun; Chad R Heatwole; Michael P McDermott; Tian Chen; Melissa Cline; Rabi Tawil; Robert J Osborne; Thurman M Wheeler; Maurice S Swanson; Richard T Moxley; Charles A Thornton
Journal:  Ann Neurol       Date:  2013-12       Impact factor: 10.422

Review 7.  Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Authors:  Samantha LoRusso; Benjamin Weiner; W David Arnold
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

8.  Alternative splicing for members of human mosaic domain superfamilies. I. The CH and LIM domains containing group of proteins.

Authors:  Felix Friedberg
Journal:  Mol Biol Rep       Date:  2008-06-16       Impact factor: 2.316

Review 9.  The role of α-dystrobrevin in striated muscle.

Authors:  Masayuki Nakamori; Masanori P Takahashi
Journal:  Int J Mol Sci       Date:  2011-03-04       Impact factor: 5.923

10.  hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies.

Authors:  Matthew S Alexander; Rylie M Hightower; Andrea L Reid; Alexis H Bennett; Lakshmanan Iyer; Donna K Slonim; Madhurima Saha; Genri Kawahara; Louis M Kunkel; Alan S Kopin; Vandana A Gupta; Peter B Kang; Isabelle Draper
Journal:  Muscle Nerve       Date:  2021-03-22       Impact factor: 3.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.